tradingkey.logo

tradingkey.logo
怜玢


Vistagen Therapeutics Inc

VTGN
りォッチリストに远加
0.181USD
+0.002+1.12%
終倀 11-13 16:00ET
8.03M時䟡総額
損倱額盎近12ヶ月PER
時間倖取匕 19:04 (ET)0.179USD-0.001-0.56%

Vistagen Therapeutics Incに぀いお 䌁業名

Vistagen Therapeutics, Inc. is a late clinical-stage biopharmaceutical company. The Company is leveraging a deep understanding of nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines. Pherines specifically and selectively bind as agonists on peripheral receptors on human nasal chemosensory neurons and are designed to activate olfactory bulb-to-brain neurocircuits believed to regulate brain areas involved in behavior and autonomic nervous system activity. Its neuroscience product candidates include Fasedienol, Itruvone, PH15, PH80, and PH284. Fasedienol, its lead clinical-stage product candidate, is a synthetic neuroactive intranasal pherine in an ongoing U.S. registration-directed Phase III clinical development program for the acute treatment of anxiety in adults with SAD. Its neuroscience pipeline also includes an oral prodrug with potential to treat certain neurological conditions involving the NMDA receptor.

Vistagen Therapeutics Inc プロフィヌル


䌁業コヌドVTGN
䌚瀟名Vistagen Therapeutics Inc
䞊堎日Oct 18, 2010
最高経営責任者「CEO」Singh (Shawn K)
埓業員数56
蚌刞皮類Ordinary Share
決算期末Oct 18
本瀟所圚地343 Allerton Avenue
郜垂SOUTH SAN FRANCISCO
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号94080
電話番号16505773600
りェブサむトhttps://www.vistagen.com/
䌁業コヌドVTGN
䞊堎日Oct 18, 2010
最高経営責任者「CEO」Singh (Shawn K)

Vistagen Therapeutics Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Shawn K. Singh, J.D.
Mr. Shawn K. Singh, J.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
--
Mr. Joshua S. Prince
Mr. Joshua S. Prince
Chief Operating Officer
Chief Operating Officer
15.25K
--
Mr. Nick B. Tressler
Mr. Nick B. Tressler
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
11.71K
--
Mr. Jon S. Saxe, J.D.
Mr. Jon S. Saxe, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.86K
--
Mr. Mark A. Mcpartland
Mr. Mark A. Mcpartland
Senior Vice President - Investor Relations
Senior Vice President - Investor Relations
--
--
Ms. Ann Michelle Cunningham
Ms. Ann Michelle Cunningham
Independent Director
Independent Director
--
--
Dr. Joanne Curley, Ph.D.
Dr. Joanne Curley, Ph.D.
Independent Director
Independent Director
--
--
Ms. Mary L. Rotunno
Ms. Mary L. Rotunno
Independent Director
Independent Director
--
--
Ms. Margaret M. (Maggie) Fitzpatrick
Ms. Margaret M. (Maggie) Fitzpatrick
Independent Director
Independent Director
--
--
Mr. Reid G. Adler, J.D.
Mr. Reid G. Adler, J.D.
Chief Legal Officer
Chief Legal Officer
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Shawn K. Singh, J.D.
Mr. Shawn K. Singh, J.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
--
Mr. Joshua S. Prince
Mr. Joshua S. Prince
Chief Operating Officer
Chief Operating Officer
15.25K
--
Mr. Nick B. Tressler
Mr. Nick B. Tressler
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
11.71K
--
Mr. Jon S. Saxe, J.D.
Mr. Jon S. Saxe, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.86K
--
Mr. Mark A. Mcpartland
Mr. Mark A. Mcpartland
Senior Vice President - Investor Relations
Senior Vice President - Investor Relations
--
--
Ms. Ann Michelle Cunningham
Ms. Ann Michelle Cunningham
Independent Director
Independent Director
--
--

よくある質問

Vistagen Therapeutics Incの䞊䜍5名の株䞻は誰ですか


Vistagen Therapeutics Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Shawn K. Singh, J.D.

Vistagen Therapeutics IncVTGNの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Vistagen Therapeutics Incの株匏を保有しおいる機関は114瀟あり、保有株匏の総垂堎䟡倀は玄15.04Mで、党䜓の37.96%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-11849530.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。